US Patent Issued to CURASIGHT on Sept. 9 for "Positron emitting radionuclide labeled peptides for human uPAR PET imaging" (Danish Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,240, issued on Sept. 9, was assigned to CURASIGHT A/S (Copenhagen N, Denmark).

"Positron emitting radionuclide labeled peptides for human uPAR PET imaging" was invented by Andreas Kjaer (Frederiksberg, Denmark), Morten Persson (Copenhagen, Denmark) and Jacob Madsen (Copenhagen, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "There is provided a positron-emitting radionuclide labelled peptide for non-invasive PET imaging of the Urokinase-type Plasminogen Activator Receptor (uPAR) in humans. More specifically the invention relates to human uPAR PET imaging of any solid cancer disease for diagnosis, staging, treatment monitoring and especially ...